The Role of ProBNP on Prognosis in Scorpion Stings.


Journal

Wilderness & environmental medicine
ISSN: 1545-1534
Titre abrégé: Wilderness Environ Med
Pays: United States
ID NLM: 9505185

Informations de publication

Date de publication:
Jun 2021
Historique:
received: 18 06 2020
revised: 19 01 2021
accepted: 22 01 2021
pubmed: 18 5 2021
medline: 26 11 2021
entrez: 17 5 2021
Statut: ppublish

Résumé

Scorpion stings are a major health problem with potentially fatal consequences. Children under the age of 10 y especially face a great risk. Predicting the prognosis is important in reducing mortality and morbidity because it enables the use of early treatment options. In this study, we examine the relationship between proBNP and prognosis in scorpion stings. This is a retrospective analysis of patients aged ≤18 y who were admitted to the child emergency service with a scorpion sting. We examined the demographical data, clinical findings, laboratory records, treatments, and results of the patients. We classified stage 1 and stage 2 scorpion envenomation as group 1 (mild-moderate) and stage 3 and 4 as group 2 (severe). A t test was used for normally distributed data, and the Mann-Whitney U test was used for nonnormally distributed data. The correlation analysis was done using the Spearman test. There were 32 (74%) patients in the mild-moderate group and 11 (26%) in the severe group. ProBNP 1 was significantly higher in the severe group at admission (P=0.016). There was no difference between the troponin I values (P=0.051). ProBNP 2 (12th hour) and proBNP 3 (24th hour) were higher in the severe group (P=0.001 and P=0.032, respectively). There was a negative correlation between proBNP and echocardiographic findings involving ejection fraction and shortening fraction (r=-0.703, P=0.002). In our study, the first proBNP values were significantly higher in the severe group. This suggests that proBNP may be beneficial in predicting prognosis.

Identifiants

pubmed: 33994108
pii: S1080-6032(21)00020-X
doi: 10.1016/j.wem.2021.01.015
pii:
doi:

Substances chimiques

Troponin I 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

137-142

Informations de copyright

Copyright © 2021 Wilderness Medical Society. Published by Elsevier Inc. All rights reserved.

Auteurs

Ufuk Utku Güllü (UU)

Department of Pediatrics, Kahramanmaraş Sütçü İmam University Medical Faculty, Kahramanmaraş, Turkey; Department of Pediatric Cardiology, Kahramanmaraş Sütçü İmam University Medical Faculty, Kahramanmaraş, Turkey.

Sevcan İpek (S)

Department of Pediatrics, Kahramanmaraş Sütçü İmam University Medical Faculty, Kahramanmaraş, Turkey. Electronic address: drsevcanipek@gmail.com.

Tahir Dalkıran (T)

Pediatric Intensive Care Unit, Kahramanmaraş Necip Fazıl City Hospital, Kahramanmaraş, Turkey.

Serpil Dinçer (S)

Department of Pediatrics, Kahramanmaraş Sütçü İmam University Medical Faculty, Kahramanmaraş, Turkey.

Sadık Yurttutan (S)

Department of Pediatrics, Kahramanmaraş Sütçü İmam University Medical Faculty, Kahramanmaraş, Turkey; Neonatal Intensive Care Unit, Kahramanmaraş Sütçü İmam University Medical Faculty, Kahramanmaraş, Turkey.

Eser Aynacı (E)

Department of Pediatrics, Kahramanmaraş Sütçü İmam University Medical Faculty, Kahramanmaraş, Turkey; Department of Pediatric Neurology, Kahramanmaraş Sütçü İmam University Medical Faculty, Kahramanmaraş, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH